Semen Coicis Extract
Document Actions
|
|
Semen Coicis Extract |
|
|
Semen Coicis Extract |
|
|
Contains: 18c monoenoic acid, 18c dienoic acid, 16c alkyl acid and 18c alkyl acid, etc. |
|
|
K1 intravenous solutions |
|
|
Kanglaite Injection |
|
|
Parenteral Ordinary |
|
|
10 g |
|
|
2 bottles/day |
|
|
Acting on G2/M phase & blocking mitosis of cancer cells, regulating gene expressions, inducing cells apoptosis, reducing angiogenesis, inhibiting tumor growth & metastasis, reversing MDR, improving & regulating cell factors & cachexia, inhibiting activities of PKC, COX-2, MMP-9 (matrigel invasion) and FAS, etc. |
|
|
Kanglaite Injection (KLT) is a botanical anticancer drug prepared in emulsion form for intravenous use. It is produced by advanced technology with active substance from a herbal plant "semen coicis". KLT has the following features. - Effectively kills cancer cells while remarkably improves immune capacity; - Synergistic function when combined with chemotherapy or radiation therapy; - Provides high energy nutrition to treat cachexia; - Markedly relieves cancerous pain ; - Improves QOL, PPT and MST to prolong survival; - With very slight adverse reaction KLT has brought great benefits to over 550,000 cancer patients in 2,200 hospitals in China and become the market leader among all anticancer drugs in China in recent 4 years. Approved by FDA, phase I trial of KLT was conducted in 2001at Huntsman Cancer Institute, Salt Lake City, Utah, USA with inspiring result. Its mechanism was reconfirmed at Johns Hopkings University, USA. KLT clinical study in Russia began in January 2002 and ended in April 2003 with satisfactory outcomes. The registration certificate was issued from Russian Ministry of Health in Dec. 2003. KLT was launched in Russia in July 2005. |
|
|
Registered |
|
|
China, Russia |
|
|
China, Russia |
|
|
United States |
|
|
import and distribution |
|
|
Christopher Li Zhejiang Kanglaite Pharmaceutical Co,. Ltd. Add: 11th Rd., Xiasha Economic Zone, Hangzhou, China Phone: +86-571-86911888ext1207 Fax: +86-571-86911680 Email: shestli@126.com |
|
|
http://www.kanglaite.com |
|
|
Seek Overseas Agent for our Anticancer Drug - KLT A patented dual function botanical anticancer drug seeks overseas agent. The drug-Kanglaite Injection (KLT) has been on top of best selling antineoplastic agents in China with over 550,000 cases of lung, liver, breast, kidney, colon, pancreatic or stomach cancers. Phase I trial in USA, Phase II in Russia and Phase III in China have proven that KLT can directly kill cancer cells and enhance immune capacity, effectively control cancerous pain, improve QOL, PPT and MST in palliative treatment. Serious and professional foreign companies preferably in oncological line are specially welcome to contact us. Thanks. |
There are currently no items in this folder.
Last modified
2006-11-05 19:53
Contact this User
|
|
